Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?

被引：19

作者：

Pollack, A ^{[1
]}

Zagars, GK ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Dept Radiotherapy, Houston, TX USA

来源：

SEMINARS IN RADIATION ONCOLOGY | 1998年 / 8卷 / 02期

关键词：

D O I：

10.1016/S1053-4296(98)80005-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：95 / 106

页数：12

共 71 条

[1]

Abram P, 1996, J NATL CANCER I, V88, P1834

[2]

[Anonymous], 1997, Br J Urol, V79, P235

[3]

[Anonymous], 1995, Lancet, V346, P265

[4] CLINICAL AND PATHOBIOLOGICAL EFFECTS OF NEOADJUVANT TOTAL ANDROGEN ABLATION THERAPY ON CLINICALLY LOCALIZED PROSTATIC ADENOCARCINOMA [J].

ARMAS, OA ;

APRIKIAN, AG ;

MELAMED, J ;

CORDONCARDO, C ;

COHEN, DW ;

ERLANDSON, R ;

FAIR, WR ;

REUTER, VE .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (10) :979-991

[5]

BAGSHAW MA, 1984, UROL CLIN N AM, V11, P297

[6] Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin [J].

Bolla, M ;

Gonzalez, D ;

Warde, P ;

Dubois, JB ;

Mirimanoff, RO ;

Storme, G ;

Bernier, J ;

Kuten, A ;

Sternberg, C ;

Gil, T ;

Collette, L ;

Pierart, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :295-300

[7]

BYAR DP, 1980, B CANCER, V67, P477

[8]

BYAR DP, 1980, NATL CANCER I MONOGR, V7, P165

[9]

CHENG CWS, 1993, CANCER, V71, P996, DOI 10.1002/1097-0142(19930201)71:3+<996::AID-CNCR2820711417>3.0.CO

[10]

2-8

← 1 2 3 4 5 6 7 8 →